Friday, January 2, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Vail Resorts Faces Setbacks in Q2 Financial Results

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Vail Resorts faced setbacks in its Q2 financial results, reporting a decrease in total net revenue of $23.8 million, or 2.2%, for the three months ended January 31, 2024. Challenging weather conditions, including lower snowfall at North American resorts, were to blame for the decline. As a result, the company adjusted its fiscal year 2024 guidance, now anticipating net income between $270 million and $325 million and EBITDA ranging from $849 million to $885 million.

Despite the disappointing performance in skier visits, Vail Resorts remains confident in the strength of its business model and loyal customer base. Following the announcement of these financial results, the stock price of Vail Resorts (MTN) took a hit, with shares trading lower than before.

MTN Stock Price Declines on March 12, 2024: Trading Near 52-Week Low

On March 12, 2024, MTN stock experienced a decline in its price, trading near the bottom of its 52-week range and below its 200-day simple moving average. According to data from CNN Money, the price of MTN shares dropped by $4.41 since the market last closed, representing a 1.96% decrease.

The stock opened at $215.00 on March 12, which was $9.63 lower than its previous close. This indicates that there was a significant drop in the stock price at the opening bell, setting a negative tone for the trading day.

MTN Group Stock Performance Soars with Impressive Financial Results in 2024

On March 12, 2024, MTN Group’s stock performance reflected the company’s strong financial results for the past year and quarter. According to data from CNN Money, MTN Group reported a total revenue of $2.89 billion for the past year, which represents a 14.39% increase compared to the previous year. Additionally, the total revenue for the second quarter of the year was $1.08 billion, showing an impressive 316.9% increase since the previous quarter.

In terms of net income, MTN Group reported a net income of $268.15 million for the past year, which is a 22.93% decrease compared to the previous year. However, the net income for the second quarter of the year was $219.30 million, indicating a significant 224.95% increase since the previous quarter.

Earnings per share (EPS) for MTN Group were reported at $6.74 for the past year, showing a 21.13% decrease compared to the previous year. However, the EPS for the second quarter of the year was $5.76, reflecting a remarkable 225.09% increase since the previous quarter.

Tags: MTN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare tech

Revolutionizing Cardiovascular Health MyoVista Technology in Cardiovascular Diabetology

Biotricity Inc Enhances Cardiac AI Cloud Platform for Improved Profitability and Clinical DecisionMaking

Analysts Bullish on Madrigal Pharmaceuticals with Price Target Upgrades

Recommended

Finance_Budgeting (1)

Analyst Downgrades Brown Browns Outlook

2 years ago
Seaboard Stock

Seaboard Shares: Assessing the Foundation of a Rebound

2 weeks ago
Robert Half Stock

Robert Half Faces Market Headwinds Amid Sector Challenges

4 months ago
PayPal Stock

PayPal’s Strategic Push Meets Market Skepticism

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Institutional Investors Show Diverging Views on Johnson & Johnson Stock

The Tech-Heavy Engine Driving a Top Global ETF

Ethereum’s 2026 Mandate: Building Beyond Speculation

Electro Optic Systems Stock Soars on Tripled Order Backlog and New Governance Rules

Super Micro’s AI Server Launch Fails to Impress Investors

Assessing PayPal: A Value Opportunity or a Value Trap?

Trending

Bionxt Solutions Stock
Analysis

BioNxt Solutions: Clinical Milestones Set to Define 2026 Trajectory

by Andreas Sommer
January 2, 2026
0

Entering the new year, BioNxt Solutions (BNXT) carries significant momentum, with investor focus shifting from near-term volatility...

TSMC Stock

TSMC Strengthens Market Dominance with Dual Technological and Geopolitical Wins

January 2, 2026
CureVac Stock

CureVac Acquisition Enters Final Phase as BioNTech Integration Accelerates

January 2, 2026
Johnson & Johnson Stock

Institutional Investors Show Diverging Views on Johnson & Johnson Stock

January 2, 2026
MSCI World ETF Stock

The Tech-Heavy Engine Driving a Top Global ETF

January 2, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions: Clinical Milestones Set to Define 2026 Trajectory
  • TSMC Strengthens Market Dominance with Dual Technological and Geopolitical Wins
  • CureVac Acquisition Enters Final Phase as BioNTech Integration Accelerates

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com